Last Updated: November 8, 2026

Hq Speclt Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for HQ SPECLT PHARMA

HQ SPECLT PHARMA has six approved drugs.

Summary for Hq Speclt Pharma

US Patents:	0
Tradenames:	4
Ingredients:	4
NDAs:	6

Drugs and US Patents for Hq Speclt Pharma

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hq Speclt Pharma	AMPICILLIN SODIUM	ampicillin sodium	INJECTABLE;INJECTION	062772-004	Apr 15, 1993		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Hq Speclt Pharma	AMPICILLIN AND SULBACTAM	ampicillin sodium; sulbactam sodium	INJECTABLE;INJECTION	065188-001	Nov 25, 2005	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Hq Speclt Pharma	AMPICILLIN SODIUM	ampicillin sodium	INJECTABLE;INJECTION	062772-005	Apr 15, 1993		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Hq Speclt Pharma	PENICILLIN G POTASSIUM	penicillin g potassium	INJECTABLE;INJECTION	065149-002	Jul 23, 2009	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Hq Speclt Pharma	AMPICILLIN SODIUM	ampicillin sodium	INJECTABLE;INJECTION	062772-002	Apr 15, 1993		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Hq Speclt Pharma	AMPICILLIN SODIUM	ampicillin sodium	INJECTABLE;INJECTION	062772-006	Apr 15, 1993	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Hq Speclt Pharma	AMPICILLIN SODIUM	ampicillin sodium	INJECTABLE;INJECTION	063142-001	Apr 15, 1993	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.